

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.16581824 |
| 2 | central nervous system myelination (GO:0022010) | 9.16581824 |
| 3 | negative regulation of neurotransmitter secretion (GO:0046929) | 6.94603852 |
| 4 | myelination (GO:0042552) | 6.33303304 |
| 5 | axon ensheathment (GO:0008366) | 6.24103858 |
| 6 | ensheathment of neurons (GO:0007272) | 6.24103858 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.89120441 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 5.79149024 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.42045952 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.35814829 |
| 11 | fatty acid elongation (GO:0030497) | 5.00865614 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.96971587 |
| 13 | myelination in peripheral nervous system (GO:0022011) | 4.96846361 |
| 14 | peripheral nervous system axon ensheathment (GO:0032292) | 4.96846361 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.95942895 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.84751080 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.84751080 |
| 18 | astrocyte development (GO:0014002) | 4.83345393 |
| 19 | negative T cell selection (GO:0043383) | 4.82969999 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.81552428 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.67199346 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.59935532 |
| 23 | positive thymic T cell selection (GO:0045059) | 4.58025443 |
| 24 | thymic T cell selection (GO:0045061) | 4.56554056 |
| 25 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.54925553 |
| 26 | positive regulation of Rap GTPase activity (GO:0032854) | 4.52852303 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.52028113 |
| 28 | oligodendrocyte differentiation (GO:0048709) | 4.48589536 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.43503703 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42642524 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.41023137 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40219288 |
| 33 | response to interleukin-15 (GO:0070672) | 4.30675148 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 4.27758000 |
| 35 | T cell migration (GO:0072678) | 4.26268245 |
| 36 | neuron cell-cell adhesion (GO:0007158) | 4.18299157 |
| 37 | positive T cell selection (GO:0043368) | 4.15769683 |
| 38 | L-amino acid import (GO:0043092) | 4.06621837 |
| 39 | T cell selection (GO:0045058) | 4.03566285 |
| 40 | regulation of ARF protein signal transduction (GO:0032012) | 4.02910093 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.01536410 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00210952 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93800868 |
| 44 | regulation of Rap GTPase activity (GO:0032317) | 3.93439634 |
| 45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92614822 |
| 46 | synaptic vesicle maturation (GO:0016188) | 3.90546938 |
| 47 | myelin maintenance (GO:0043217) | 3.88412859 |
| 48 | glycerophospholipid catabolic process (GO:0046475) | 3.86912495 |
| 49 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.80797010 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.76144010 |
| 51 | cyclic nucleotide catabolic process (GO:0009214) | 3.69866988 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.69187708 |
| 53 | B cell homeostasis (GO:0001782) | 3.64752883 |
| 54 | tolerance induction (GO:0002507) | 3.62045712 |
| 55 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.60911789 |
| 56 | eye photoreceptor cell differentiation (GO:0001754) | 3.60548339 |
| 57 | photoreceptor cell differentiation (GO:0046530) | 3.60548339 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.60308311 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.53123389 |
| 60 | cellular response to epinephrine stimulus (GO:0071872) | 3.51743566 |
| 61 | germinal center formation (GO:0002467) | 3.49615292 |
| 62 | glutamate secretion (GO:0014047) | 3.44778877 |
| 63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44256372 |
| 64 | adult walking behavior (GO:0007628) | 3.44094240 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 3.40193279 |
| 66 | virion attachment to host cell (GO:0019062) | 3.40193279 |
| 67 | asymmetric protein localization (GO:0008105) | 3.31529040 |
| 68 | peripheral nervous system development (GO:0007422) | 3.30211706 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 3.28050572 |
| 70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.27573701 |
| 71 | amino acid import (GO:0043090) | 3.27356387 |
| 72 | regulation of collateral sprouting (GO:0048670) | 3.26928247 |
| 73 | substantia nigra development (GO:0021762) | 3.25469001 |
| 74 | signal complex assembly (GO:0007172) | 3.24984419 |
| 75 | apical protein localization (GO:0045176) | 3.22325401 |
| 76 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.22248593 |
| 77 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21451976 |
| 78 | cellular response to catecholamine stimulus (GO:0071870) | 3.21337893 |
| 79 | cellular response to monoamine stimulus (GO:0071868) | 3.21337893 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19793159 |
| 81 | negative regulation of protein localization to cell surface (GO:2000009) | 3.19138256 |
| 82 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19063159 |
| 83 | establishment of mitochondrion localization (GO:0051654) | 3.18895298 |
| 84 | dendritic spine organization (GO:0097061) | 3.18617614 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16543888 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 3.15222120 |
| 87 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12743321 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12562957 |
| 89 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 3.12510496 |
| 90 | dendritic spine morphogenesis (GO:0060997) | 3.12491538 |
| 91 | response to redox state (GO:0051775) | 3.11665150 |
| 92 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.11423739 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10410368 |
| 94 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.09229357 |
| 95 | negative regulation of synaptic transmission (GO:0050805) | 3.08532566 |
| 96 | response to muramyl dipeptide (GO:0032495) | 3.08461341 |
| 97 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.08303555 |
| 98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.07653922 |
| 99 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06533800 |
| 100 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.04528684 |
| 101 | cellular response to type I interferon (GO:0071357) | 3.04460413 |
| 102 | type I interferon signaling pathway (GO:0060337) | 3.04460413 |
| 103 | response to type I interferon (GO:0034340) | 3.02568558 |
| 104 | positive regulation of action potential (GO:0045760) | 3.02335728 |
| 105 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.01473517 |
| 106 | negative regulation of myoblast differentiation (GO:0045662) | 2.99740162 |
| 107 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99116855 |
| 108 | Peyers patch development (GO:0048541) | 2.99116855 |
| 109 | T cell costimulation (GO:0031295) | 2.98465900 |
| 110 | regulation of synaptic vesicle transport (GO:1902803) | 2.97424426 |
| 111 | response to epinephrine (GO:0071871) | 2.97354247 |
| 112 | lymphocyte costimulation (GO:0031294) | 2.95142814 |
| 113 | activated T cell proliferation (GO:0050798) | 2.94584534 |
| 114 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.94263593 |
| 115 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.94240278 |
| 116 | leukocyte aggregation (GO:0070486) | 2.93537539 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92678717 |
| 118 | response to monoamine (GO:0071867) | 2.87358918 |
| 119 | response to catecholamine (GO:0071869) | 2.87358918 |
| 120 | neuronal ion channel clustering (GO:0045161) | 2.86644714 |
| 121 | interferon-gamma production (GO:0032609) | 2.85439638 |
| 122 | synaptic transmission, glutamatergic (GO:0035249) | 2.85291277 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.84275071 |
| 124 | centrosome duplication (GO:0051298) | 2.83645624 |
| 125 | membrane assembly (GO:0071709) | 2.82966479 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.82112876 |
| 127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82082015 |
| 128 | regulation of dendritic spine development (GO:0060998) | 2.81868643 |
| 129 | negative regulation of axonogenesis (GO:0050771) | 2.81320315 |
| 130 | positive regulation of interleukin-2 production (GO:0032743) | 2.80606146 |
| 131 | glial cell development (GO:0021782) | 2.80098938 |
| 132 | T cell receptor signaling pathway (GO:0050852) | 2.80069998 |
| 133 | T cell homeostasis (GO:0043029) | 2.79796706 |
| 134 | neuron-neuron synaptic transmission (GO:0007270) | 2.79102272 |
| 135 | natural killer cell differentiation (GO:0001779) | 2.78084081 |
| 136 | mast cell activation (GO:0045576) | 2.77594071 |
| 137 | import into cell (GO:0098657) | 2.77119167 |
| 138 | sodium ion export (GO:0071436) | 2.76282899 |
| 139 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.76268914 |
| 140 | positive regulation of dendritic spine development (GO:0060999) | 2.76198495 |
| 141 | nerve growth factor signaling pathway (GO:0038180) | 2.76189692 |
| 142 | protein localization to synapse (GO:0035418) | 2.74910053 |
| 143 | locomotory exploration behavior (GO:0035641) | 2.74533618 |
| 144 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73492655 |
| 145 | modulation by symbiont of host defense response (GO:0052031) | 2.73492655 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73492655 |
| 147 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73492655 |
| 148 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73492655 |
| 149 | modulation by symbiont of host immune response (GO:0052553) | 2.73492655 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71742014 |
| 151 | myeloid dendritic cell activation (GO:0001773) | 2.71736588 |
| 152 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71731956 |
| 153 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.69424634 |
| 154 | limb bud formation (GO:0060174) | 2.69155139 |
| 155 | gamma-aminobutyric acid transport (GO:0015812) | 2.68598631 |
| 156 | cellular potassium ion homeostasis (GO:0030007) | 2.68349657 |
| 157 | glutamate receptor signaling pathway (GO:0007215) | 2.68195467 |
| 158 | vocalization behavior (GO:0071625) | 2.67887348 |
| 159 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67350378 |
| 160 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.67194363 |
| 161 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.66514987 |
| 162 | B cell proliferation (GO:0042100) | 2.65964352 |
| 163 | lymphocyte migration (GO:0072676) | 2.65460164 |
| 164 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.64150254 |
| 165 | detection of bacterium (GO:0016045) | 2.62459624 |
| 166 | neurotransmitter secretion (GO:0007269) | 2.61132753 |
| 167 | regulation of interleukin-4 production (GO:0032673) | 2.60843631 |
| 168 | dendrite development (GO:0016358) | 2.60247675 |
| 169 | neurotransmitter uptake (GO:0001504) | 2.60157443 |
| 170 | myelin assembly (GO:0032288) | 2.59973232 |
| 171 | positive regulation of membrane potential (GO:0045838) | 2.59893350 |
| 172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59663041 |
| 173 | positive regulation of granulocyte differentiation (GO:0030854) | 2.59024714 |
| 174 | positive regulation of interleukin-4 production (GO:0032753) | 2.58856620 |
| 175 | cholesterol biosynthetic process (GO:0006695) | 2.58599180 |
| 176 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.57735349 |
| 177 | negative regulation of axon extension (GO:0030517) | 2.57648048 |
| 178 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.57426255 |
| 179 | regulation of glutamate secretion (GO:0014048) | 2.57309682 |
| 180 | creatine metabolic process (GO:0006600) | 2.57177214 |
| 181 | GPI anchor biosynthetic process (GO:0006506) | 2.56853695 |
| 182 | neuron recognition (GO:0008038) | 2.55348403 |
| 183 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54464806 |
| 184 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54464806 |
| 185 | cAMP catabolic process (GO:0006198) | 2.53860566 |
| 186 | postsynaptic membrane organization (GO:0001941) | 2.53469644 |
| 187 | regulation of B cell proliferation (GO:0030888) | 2.53149032 |
| 188 | regulation of establishment of cell polarity (GO:2000114) | 2.52854924 |
| 189 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52841637 |
| 190 | membrane tubulation (GO:0097320) | 2.52496742 |
| 191 | macrophage activation involved in immune response (GO:0002281) | 2.52302934 |
| 192 | positive regulation of B cell activation (GO:0050871) | 2.51848493 |
| 193 | mast cell activation involved in immune response (GO:0002279) | 2.51167427 |
| 194 | startle response (GO:0001964) | 2.48192090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.82797514 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27334590 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.97499689 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.93942534 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.81910116 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.28333427 |
| 7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05407242 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.81050101 |
| 9 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.80904115 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61156370 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60579078 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60320834 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.60049809 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59901173 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59246700 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.57706994 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.54514148 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52313196 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49062730 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.48056930 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.46960867 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.45122411 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.42439715 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35320382 |
| 25 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.33473314 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29220145 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.28859043 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27076481 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25161205 |
| 30 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23465689 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.23234419 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21687044 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19061001 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19061001 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17368615 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16262829 |
| 37 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.12633691 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10971856 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10570882 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09866846 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.09709593 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08725262 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.08704440 |
| 44 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.08520374 |
| 45 | * MYB_26560356_Chip-Seq_TH1_Human | 2.08240796 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07434595 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05832760 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03098569 |
| 49 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02217244 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01081874 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00800043 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.99705071 |
| 53 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97958608 |
| 54 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97388658 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95652294 |
| 56 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95252914 |
| 57 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94925144 |
| 58 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89447304 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84508496 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82551272 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81647169 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79090370 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78569261 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78535127 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.76273678 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74685432 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.73001231 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72669424 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70256369 |
| 70 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69698640 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.64739836 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.63751655 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62553510 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62441151 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60029951 |
| 76 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57940477 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57706461 |
| 78 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56773725 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56311042 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55168412 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53924364 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53797663 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52331853 |
| 84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51927667 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48848050 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48728491 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46889777 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46828901 |
| 89 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45073519 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44323718 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43523857 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41488532 |
| 93 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41452063 |
| 94 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41093337 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40425508 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39585081 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37382538 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36462429 |
| 99 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.36242406 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34637053 |
| 101 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34548419 |
| 102 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.32504980 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31861653 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30319773 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28986925 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28141609 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27496253 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26376407 |
| 109 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25280214 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24761227 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24386827 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24270378 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24223232 |
| 114 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24024015 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22784672 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21426767 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21238752 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21191920 |
| 119 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18980551 |
| 120 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18790911 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18345481 |
| 122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17590835 |
| 123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16429167 |
| 124 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15007600 |
| 125 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.14726610 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14635108 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13966772 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13832276 |
| 129 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13795996 |
| 130 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13578221 |
| 131 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13350816 |
| 132 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13037809 |
| 133 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.12743018 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11990302 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10834519 |
| 136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10676487 |
| 137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10263966 |
| 138 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09917516 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09886682 |
| 140 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09415989 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08789233 |
| 142 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08468308 |
| 143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08403512 |
| 144 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07665292 |
| 145 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07268038 |
| 146 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07244156 |
| 147 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07023906 |
| 148 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06929447 |
| 149 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06847532 |
| 150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05590612 |
| 151 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04394146 |
| 152 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03990097 |
| 153 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03530162 |
| 154 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03229321 |
| 155 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03185123 |
| 156 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00526271 |
| 157 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00430014 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00228150 |
| 159 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00113372 |
| 160 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99977512 |
| 161 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99977512 |
| 162 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99966653 |
| 163 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99903259 |
| 164 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99372361 |
| 165 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99148954 |
| 166 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.98871666 |
| 167 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.98595304 |
| 168 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98230928 |
| 169 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98143620 |
| 170 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98137494 |
| 171 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98081191 |
| 172 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97744776 |
| 173 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97470412 |
| 174 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97466800 |
| 175 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97016249 |
| 176 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96981650 |
| 177 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96463105 |
| 178 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95879035 |
| 179 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95264435 |
| 180 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92922542 |
| 181 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91735189 |
| 182 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91415917 |
| 183 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91195425 |
| 184 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88705687 |
| 185 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.88113318 |
| 186 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87502387 |
| 187 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83835670 |
| 188 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83415404 |
| 189 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81943083 |
| 190 | P68_20966046_ChIP-Seq_HELA_Human | 0.81705438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.68383874 |
| 2 | MP0000920_abnormal_myelination | 4.52841217 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.56874172 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.51971070 |
| 5 | MP0003303_peritoneal_inflammation | 3.35250121 |
| 6 | MP0005671_abnormal_response_to | 3.34212172 |
| 7 | MP0003690_abnormal_glial_cell | 3.32226213 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.18957703 |
| 9 | MP0000685_abnormal_immune_system | 3.08079951 |
| 10 | MP0004270_analgesia | 3.05495419 |
| 11 | MP0003950_abnormal_plasma_membrane | 3.01268653 |
| 12 | MP0001800_abnormal_humoral_immune | 3.00305039 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.95037707 |
| 14 | MP0001790_abnormal_immune_system | 2.91346700 |
| 15 | MP0005387_immune_system_phenotype | 2.91346700 |
| 16 | MP0003136_yellow_coat_color | 2.86514627 |
| 17 | MP0002272_abnormal_nervous_system | 2.82733177 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.80257732 |
| 19 | MP0002064_seizures | 2.79360094 |
| 20 | MP0001486_abnormal_startle_reflex | 2.70548985 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 2.69697119 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.68552917 |
| 23 | MP0009745_abnormal_behavioral_response | 2.62808141 |
| 24 | MP0003436_decreased_susceptibility_to | 2.60081056 |
| 25 | MP0001905_abnormal_dopamine_level | 2.58758536 |
| 26 | MP0005409_darkened_coat_color | 2.49871809 |
| 27 | MP0004742_abnormal_vestibular_system | 2.46000268 |
| 28 | MP0009046_muscle_twitch | 2.43320428 |
| 29 | MP0005171_absent_coat_pigmentation | 2.35457563 |
| 30 | MP0002723_abnormal_immune_serum | 2.30589605 |
| 31 | MP0002420_abnormal_adaptive_immunity | 2.29410610 |
| 32 | MP0004885_abnormal_endolymph | 2.29092671 |
| 33 | MP0001819_abnormal_immune_cell | 2.24235560 |
| 34 | MP0004142_abnormal_muscle_tone | 2.24006116 |
| 35 | MP0001529_abnormal_vocalization | 2.21348390 |
| 36 | MP0002452_abnormal_antigen_presenting | 2.19188952 |
| 37 | MP0002398_abnormal_bone_marrow | 2.16132691 |
| 38 | MP0002063_abnormal_learning/memory/cond | 2.16025540 |
| 39 | MP0000778_abnormal_nervous_system | 2.07372458 |
| 40 | MP0001348_abnormal_lacrimal_gland | 2.03816706 |
| 41 | MP0001485_abnormal_pinna_reflex | 2.00970700 |
| 42 | MP0002822_catalepsy | 2.00866528 |
| 43 | MP0002572_abnormal_emotion/affect_behav | 2.00630182 |
| 44 | MP0003634_abnormal_glial_cell | 1.97888095 |
| 45 | MP0000716_abnormal_immune_system | 1.93069124 |
| 46 | MP0008569_lethality_at_weaning | 1.91657705 |
| 47 | MP0005025_abnormal_response_to | 1.91261573 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.90375182 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.89690241 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.82060746 |
| 51 | MP0002734_abnormal_mechanical_nocicepti | 1.80599069 |
| 52 | MP0002229_neurodegeneration | 1.78820730 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.73639428 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.68641274 |
| 55 | MP0003329_amyloid_beta_deposits | 1.68551293 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.66599755 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.66324940 |
| 58 | MP0001873_stomach_inflammation | 1.64617633 |
| 59 | MP0005310_abnormal_salivary_gland | 1.62313016 |
| 60 | MP0004924_abnormal_behavior | 1.61775017 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.61775017 |
| 62 | MP0002419_abnormal_innate_immunity | 1.59314790 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.58219250 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.57870363 |
| 65 | MP0001188_hyperpigmentation | 1.56959888 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.56389468 |
| 67 | MP0004947_skin_inflammation | 1.55779673 |
| 68 | MP0004134_abnormal_chest_morphology | 1.54621878 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.54037787 |
| 70 | MP0003866_abnormal_defecation | 1.53735086 |
| 71 | MP0004381_abnormal_hair_follicle | 1.52437344 |
| 72 | MP0003724_increased_susceptibility_to | 1.51297057 |
| 73 | MP0002722_abnormal_immune_system | 1.50879349 |
| 74 | MP0002429_abnormal_blood_cell | 1.48695571 |
| 75 | MP0002405_respiratory_system_inflammati | 1.46230913 |
| 76 | MP0009785_altered_susceptibility_to | 1.44523531 |
| 77 | MP0003938_abnormal_ear_development | 1.44083282 |
| 78 | MP0002882_abnormal_neuron_morphology | 1.44053083 |
| 79 | MP0001968_abnormal_touch/_nociception | 1.43879200 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.42984306 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.41625591 |
| 82 | MP0000955_abnormal_spinal_cord | 1.38074503 |
| 83 | MP0004510_myositis | 1.37657170 |
| 84 | MP0003632_abnormal_nervous_system | 1.37369777 |
| 85 | MP0003633_abnormal_nervous_system | 1.37369206 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.36998761 |
| 87 | MP0003631_nervous_system_phenotype | 1.35524460 |
| 88 | MP0001177_atelectasis | 1.34625927 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.31609032 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.31424409 |
| 91 | MP0001502_abnormal_circadian_rhythm | 1.30859189 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.28975938 |
| 93 | MP0001970_abnormal_pain_threshold | 1.28243012 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 1.24107484 |
| 95 | MP0005410_abnormal_fertilization | 1.23978126 |
| 96 | MP0001501_abnormal_sleep_pattern | 1.23030576 |
| 97 | MP0002006_tumorigenesis | 1.20660367 |
| 98 | MP0001963_abnormal_hearing_physiology | 1.18100657 |
| 99 | MP0001845_abnormal_inflammatory_respons | 1.17763054 |
| 100 | MP0002735_abnormal_chemical_nociception | 1.16998684 |
| 101 | MP0003045_fibrosis | 1.15034109 |
| 102 | MP0005464_abnormal_platelet_physiology | 1.12896158 |
| 103 | MP0002009_preneoplasia | 1.12150352 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.10679301 |
| 105 | MP0002752_abnormal_somatic_nervous | 1.10527540 |
| 106 | MP0002933_joint_inflammation | 1.07776216 |
| 107 | MP0003172_abnormal_lysosome_physiology | 1.07393508 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 1.06492439 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 1.05945134 |
| 110 | MP0002733_abnormal_thermal_nociception | 1.05232157 |
| 111 | MP0008057_abnormal_DNA_replication | 1.03914458 |
| 112 | MP0002736_abnormal_nociception_after | 1.03640434 |
| 113 | MP0003075_altered_response_to | 1.01768697 |
| 114 | MP0001853_heart_inflammation | 1.01553966 |
| 115 | MP0001299_abnormal_eye_distance/ | 1.01411693 |
| 116 | MP0002152_abnormal_brain_morphology | 1.01003968 |
| 117 | MP0001851_eye_inflammation | 1.00116428 |
| 118 | MP0005166_decreased_susceptibility_to | 0.94722251 |
| 119 | MP0008874_decreased_physiological_sensi | 0.92825901 |
| 120 | MP0006082_CNS_inflammation | 0.91601559 |
| 121 | MP0002184_abnormal_innervation | 0.89984899 |
| 122 | MP0004043_abnormal_pH_regulation | 0.89468668 |
| 123 | MP0003091_abnormal_cell_migration | 0.89121298 |
| 124 | MP0004147_increased_porphyrin_level | 0.87754996 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.86959954 |
| 126 | MP0000026_abnormal_inner_ear | 0.86770591 |
| 127 | MP0003879_abnormal_hair_cell | 0.85633615 |
| 128 | MP0006292_abnormal_olfactory_placode | 0.84044954 |
| 129 | MP0003787_abnormal_imprinting | 0.80848986 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.79463186 |
| 131 | MP0008260_abnormal_autophagy | 0.78957986 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.76278721 |
| 133 | MP0005535_abnormal_body_temperature | 0.75824597 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.75041731 |
| 135 | MP0000566_synostosis | 0.72812960 |
| 136 | MP0005451_abnormal_body_composition | 0.71174860 |
| 137 | MP0009278_abnormal_bone_marrow | 0.70262568 |
| 138 | MP0001879_abnormal_lymphatic_vessel | 0.69974095 |
| 139 | MP0000462_abnormal_digestive_system | 0.69389337 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.69376546 |
| 141 | MP0005195_abnormal_posterior_eye | 0.67467865 |
| 142 | MP0001664_abnormal_digestion | 0.67387429 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.66715370 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.66250202 |
| 145 | MP0005253_abnormal_eye_physiology | 0.65576077 |
| 146 | MP0002083_premature_death | 0.64994846 |
| 147 | MP0002751_abnormal_autonomic_nervous | 0.64614904 |
| 148 | MP0000604_amyloidosis | 0.63955105 |
| 149 | MP0000639_abnormal_adrenal_gland | 0.63711483 |
| 150 | MP0003011_delayed_dark_adaptation | 0.63496448 |
| 151 | MP0003937_abnormal_limbs/digits/tail_de | 0.63100301 |
| 152 | MP0005388_respiratory_system_phenotype | 0.62187460 |
| 153 | MP0002133_abnormal_respiratory_system | 0.62187460 |
| 154 | MP0000383_abnormal_hair_follicle | 0.59949184 |
| 155 | MP0001986_abnormal_taste_sensitivity | 0.59929457 |
| 156 | MP0001943_abnormal_respiration | 0.59652142 |
| 157 | MP0001984_abnormal_olfaction | 0.58659850 |
| 158 | MP0000747_muscle_weakness | 0.58534915 |
| 159 | MP0000015_abnormal_ear_pigmentation | 0.56622239 |
| 160 | MP0003861_abnormal_nervous_system | 0.54685111 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.52015042 |
| 162 | MP0002069_abnormal_eating/drinking_beha | 0.51276160 |
| 163 | MP0004133_heterotaxia | 0.50009174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sensory axonal neuropathy (HP:0003390) | 5.54671207 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.46939701 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.46939701 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.92172405 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 4.61206519 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.59655208 |
| 7 | Pheochromocytoma (HP:0002666) | 4.38730213 |
| 8 | Papilledema (HP:0001085) | 4.20708057 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.02395424 |
| 10 | Abnormal auditory evoked potentials (HP:0006958) | 3.93095307 |
| 11 | Atonic seizures (HP:0010819) | 3.87051330 |
| 12 | Meningitis (HP:0001287) | 3.83284290 |
| 13 | Spastic gait (HP:0002064) | 3.81188377 |
| 14 | Focal motor seizures (HP:0011153) | 3.77541746 |
| 15 | Neuroendocrine neoplasm (HP:0100634) | 3.75292959 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72262148 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.66991372 |
| 18 | Peripheral hypomyelination (HP:0007182) | 3.65528341 |
| 19 | Recurrent viral infections (HP:0004429) | 3.64258251 |
| 20 | Myokymia (HP:0002411) | 3.63783507 |
| 21 | Colitis (HP:0002583) | 3.62183850 |
| 22 | Aqueductal stenosis (HP:0002410) | 3.61168987 |
| 23 | Cellulitis (HP:0100658) | 3.56858030 |
| 24 | Abnormality of binocular vision (HP:0011514) | 3.52869389 |
| 25 | Diplopia (HP:0000651) | 3.52869389 |
| 26 | Recurrent bronchitis (HP:0002837) | 3.49698929 |
| 27 | Dysmetria (HP:0001310) | 3.48612235 |
| 28 | Akinesia (HP:0002304) | 3.46430737 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.37669629 |
| 30 | IgM deficiency (HP:0002850) | 3.37219350 |
| 31 | Lymphopenia (HP:0001888) | 3.36657561 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.35473147 |
| 33 | Parakeratosis (HP:0001036) | 3.35354718 |
| 34 | Vasculitis (HP:0002633) | 3.35137246 |
| 35 | Abnormality of the parathyroid morphology (HP:0011766) | 3.34434193 |
| 36 | Recurrent sinusitis (HP:0011108) | 3.27149340 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.24597990 |
| 38 | Epileptic encephalopathy (HP:0200134) | 3.19225179 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.17738936 |
| 40 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.15690774 |
| 41 | Relative macrocephaly (HP:0004482) | 3.14947764 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 3.14360291 |
| 43 | T lymphocytopenia (HP:0005403) | 3.13093918 |
| 44 | Scanning speech (HP:0002168) | 3.12837760 |
| 45 | Lower limb muscle weakness (HP:0007340) | 3.10521709 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 3.10446626 |
| 47 | Recurrent fungal infections (HP:0002841) | 3.09113802 |
| 48 | IgA deficiency (HP:0002720) | 3.08633656 |
| 49 | Papilloma (HP:0012740) | 3.05735575 |
| 50 | Verrucae (HP:0200043) | 3.05735575 |
| 51 | Spontaneous hematomas (HP:0007420) | 3.05211293 |
| 52 | Hypoplastic pelvis (HP:0008839) | 3.00798551 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.99904892 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.99079769 |
| 55 | Intention tremor (HP:0002080) | 2.98691234 |
| 56 | Hemiplegia (HP:0002301) | 2.97744012 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.95858907 |
| 58 | Onion bulb formation (HP:0003383) | 2.93018076 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89135136 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89135136 |
| 61 | Abnormality of T cells (HP:0002843) | 2.83127671 |
| 62 | Alacrima (HP:0000522) | 2.78129810 |
| 63 | Abnormality of the nasal septum (HP:0000419) | 2.76055096 |
| 64 | Absent septum pellucidum (HP:0001331) | 2.74457001 |
| 65 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.72920580 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.72439281 |
| 67 | Obstructive sleep apnea (HP:0002870) | 2.71959138 |
| 68 | IgG deficiency (HP:0004315) | 2.71001779 |
| 69 | Annular pancreas (HP:0001734) | 2.68925413 |
| 70 | Septo-optic dysplasia (HP:0100842) | 2.68522219 |
| 71 | Thickened helices (HP:0000391) | 2.65227252 |
| 72 | Duplicated collecting system (HP:0000081) | 2.64358859 |
| 73 | Encephalitis (HP:0002383) | 2.64013792 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.63757986 |
| 75 | Emphysema (HP:0002097) | 2.61742572 |
| 76 | Increased IgE level (HP:0003212) | 2.61057223 |
| 77 | Autoamputation (HP:0001218) | 2.60532606 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.59338719 |
| 79 | Insidious onset (HP:0003587) | 2.58156445 |
| 80 | Termporal pattern (HP:0011008) | 2.58156445 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 2.57359439 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.56643074 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.51748186 |
| 84 | Chronic diarrhea (HP:0002028) | 2.48953496 |
| 85 | Abnormality of the renal collecting system (HP:0004742) | 2.47465571 |
| 86 | Ankle clonus (HP:0011448) | 2.44316707 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 2.44274690 |
| 88 | Increased circulating renin level (HP:0000848) | 2.43892550 |
| 89 | Visual hallucinations (HP:0002367) | 2.43469006 |
| 90 | Restrictive lung disease (HP:0002091) | 2.42420389 |
| 91 | Broad-based gait (HP:0002136) | 2.40285893 |
| 92 | Osteomyelitis (HP:0002754) | 2.39618227 |
| 93 | Optic neuritis (HP:0100653) | 2.39546166 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.39546166 |
| 95 | Bowel incontinence (HP:0002607) | 2.37015924 |
| 96 | Abnormality of the septum pellucidum (HP:0007375) | 2.34895974 |
| 97 | Abnormality of the fingertips (HP:0001211) | 2.34644975 |
| 98 | Chronic otitis media (HP:0000389) | 2.34215744 |
| 99 | Premature skin wrinkling (HP:0100678) | 2.33137657 |
| 100 | Viral hepatitis (HP:0006562) | 2.32875188 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 2.32460452 |
| 102 | Hypomagnesemia (HP:0002917) | 2.31747220 |
| 103 | Diminished movement (HP:0002374) | 2.31472772 |
| 104 | Decreased lacrimation (HP:0000633) | 2.31465895 |
| 105 | Myositis (HP:0100614) | 2.30014653 |
| 106 | Abnormal large intestine physiology (HP:0012700) | 2.25656969 |
| 107 | Stomatitis (HP:0010280) | 2.24661232 |
| 108 | Hyperventilation (HP:0002883) | 2.23616062 |
| 109 | Clumsiness (HP:0002312) | 2.22817544 |
| 110 | B lymphocytopenia (HP:0010976) | 2.21930762 |
| 111 | Recurrent abscess formation (HP:0002722) | 2.21837054 |
| 112 | Chest pain (HP:0100749) | 2.20789461 |
| 113 | Paraparesis (HP:0002385) | 2.19406277 |
| 114 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19256087 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.18886981 |
| 116 | Basal cell carcinoma (HP:0002671) | 2.18171924 |
| 117 | Abnormality of B cell number (HP:0010975) | 2.17922539 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 2.16403464 |
| 119 | Morphological abnormality of the inner ear (HP:0011390) | 2.15407203 |
| 120 | Recurrent skin infections (HP:0001581) | 2.15043656 |
| 121 | Focal seizures (HP:0007359) | 2.14724672 |
| 122 | Febrile seizures (HP:0002373) | 2.13617548 |
| 123 | Midline defect of the nose (HP:0004122) | 2.13369680 |
| 124 | Dysdiadochokinesis (HP:0002075) | 2.12979110 |
| 125 | Metabolic alkalosis (HP:0200114) | 2.12693678 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12253172 |
| 127 | Obstructive lung disease (HP:0006536) | 2.12253172 |
| 128 | Truncal ataxia (HP:0002078) | 2.12113509 |
| 129 | Orchitis (HP:0100796) | 2.10506558 |
| 130 | Macroorchidism (HP:0000053) | 2.09940766 |
| 131 | Tetraplegia (HP:0002445) | 2.08849853 |
| 132 | Absent/shortened dynein arms (HP:0200106) | 2.05480904 |
| 133 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05480904 |
| 134 | Dysmetric saccades (HP:0000641) | 2.04957739 |
| 135 | Lymphoma (HP:0002665) | 2.03640311 |
| 136 | Pulmonary embolism (HP:0002204) | 2.03305124 |
| 137 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.01887758 |
| 138 | Increased IgM level (HP:0003496) | 2.00986809 |
| 139 | Leukodystrophy (HP:0002415) | 2.00738076 |
| 140 | Granulocytopenia (HP:0001913) | 2.00465583 |
| 141 | Optic nerve hypoplasia (HP:0000609) | 1.98942170 |
| 142 | Postural instability (HP:0002172) | 1.98450337 |
| 143 | Sepsis (HP:0100806) | 1.97959352 |
| 144 | Hemoptysis (HP:0002105) | 1.97233316 |
| 145 | Pustule (HP:0200039) | 1.97139819 |
| 146 | Abnormality of saccadic eye movements (HP:0000570) | 1.96948869 |
| 147 | Limb dystonia (HP:0002451) | 1.96440542 |
| 148 | Abnormality of macrophages (HP:0004311) | 1.94563526 |
| 149 | Retinal dysplasia (HP:0007973) | 1.94441168 |
| 150 | Split foot (HP:0001839) | 1.93397129 |
| 151 | Widely spaced teeth (HP:0000687) | 1.93222426 |
| 152 | Poor eye contact (HP:0000817) | 1.90937459 |
| 153 | Anomalous pulmonary venous return (HP:0010772) | 1.90512832 |
| 154 | Poor speech (HP:0002465) | 1.89055050 |
| 155 | Recurrent otitis media (HP:0000403) | 1.88799534 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.88728238 |
| 157 | Memory impairment (HP:0002354) | 1.87564302 |
| 158 | Bronchitis (HP:0012387) | 1.87105882 |
| 159 | Severe combined immunodeficiency (HP:0004430) | 1.85848671 |
| 160 | Teleangiectasia of the skin (HP:0100585) | 1.85492527 |
| 161 | Absent speech (HP:0001344) | 1.84079411 |
| 162 | Epileptiform EEG discharges (HP:0011182) | 1.81071785 |
| 163 | Conical tooth (HP:0000698) | 1.80318851 |
| 164 | CNS hypomyelination (HP:0003429) | 1.80130943 |
| 165 | Abnormality of the astrocytes (HP:0100707) | 1.79994331 |
| 166 | Astrocytoma (HP:0009592) | 1.79994331 |
| 167 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79619132 |
| 168 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79619132 |
| 169 | Aplasia involving bones of the extremities (HP:0009825) | 1.79619132 |
| 170 | Overgrowth (HP:0001548) | 1.77003860 |
| 171 | White forelock (HP:0002211) | 1.75441731 |
| 172 | Action tremor (HP:0002345) | 1.75048954 |
| 173 | Seborrheic dermatitis (HP:0001051) | 1.73096591 |
| 174 | Abnormality of magnesium homeostasis (HP:0004921) | 1.72194517 |
| 175 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71902985 |
| 176 | Atelectasis (HP:0100750) | 1.71746330 |
| 177 | Dysphonia (HP:0001618) | 1.71480335 |
| 178 | Abnormality of the pulmonary veins (HP:0011718) | 1.70541145 |
| 179 | Hypsarrhythmia (HP:0002521) | 1.69390758 |
| 180 | Patchy hypopigmentation of hair (HP:0011365) | 1.69348105 |
| 181 | Specific learning disability (HP:0001328) | 1.68917522 |
| 182 | Prominent occiput (HP:0000269) | 1.68370404 |
| 183 | Hypokalemic alkalosis (HP:0001949) | 1.67738778 |
| 184 | Megalencephaly (HP:0001355) | 1.67189921 |
| 185 | Blue irides (HP:0000635) | 1.66197364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.46853421 |
| 2 | MAP4K1 | 4.20852271 |
| 3 | STK39 | 3.57226556 |
| 4 | LATS1 | 3.36050727 |
| 5 | CASK | 3.22627823 |
| 6 | OXSR1 | 2.93475049 |
| 7 | NUAK1 | 2.69885853 |
| 8 | TNIK | 2.21930800 |
| 9 | SIK2 | 2.19638055 |
| 10 | CAMKK1 | 2.11510833 |
| 11 | PRPF4B | 10.4425023 |
| 12 | EPHA4 | 1.92445196 |
| 13 | EPHB1 | 1.92378982 |
| 14 | JAK1 | 1.87213998 |
| 15 | DAPK2 | 1.77925634 |
| 16 | SYK | 1.74672589 |
| 17 | PKN1 | 1.73095987 |
| 18 | BCR | 1.71332503 |
| 19 | CDK19 | 1.64135064 |
| 20 | MAP3K10 | 1.53711650 |
| 21 | TYK2 | 1.52236746 |
| 22 | FGFR4 | 1.50773984 |
| 23 | BTK | 1.47980918 |
| 24 | IKBKE | 1.47909601 |
| 25 | NEK6 | 1.45028389 |
| 26 | CLK1 | 1.44973097 |
| 27 | BLK | 1.38338015 |
| 28 | FES | 1.33532431 |
| 29 | ERN1 | 1.33144881 |
| 30 | KSR2 | 1.32701469 |
| 31 | MAP3K9 | 1.32545630 |
| 32 | MAPK12 | 1.32529640 |
| 33 | WNK1 | 1.32006758 |
| 34 | SMG1 | 1.26804597 |
| 35 | UHMK1 | 1.20841487 |
| 36 | SIK3 | 1.19846058 |
| 37 | ROCK2 | 1.17390353 |
| 38 | FGFR2 | 1.16172974 |
| 39 | WNK4 | 1.16049412 |
| 40 | FGFR3 | 1.15663464 |
| 41 | JAK3 | 1.14869835 |
| 42 | TYRO3 | 1.11666277 |
| 43 | HCK | 1.09204135 |
| 44 | SGK223 | 1.08055065 |
| 45 | SGK494 | 1.08055065 |
| 46 | NTRK3 | 1.07206410 |
| 47 | CAMK2B | 1.06569592 |
| 48 | TBK1 | 1.06471261 |
| 49 | MAP3K13 | 1.02411982 |
| 50 | EEF2K | 1.01434421 |
| 51 | CSNK1A1L | 0.99775847 |
| 52 | CSNK1G3 | 0.99181177 |
| 53 | CDK12 | 0.98099974 |
| 54 | PAK6 | 0.96473836 |
| 55 | LCK | 0.95267198 |
| 56 | TEC | 0.94950227 |
| 57 | ZAP70 | 0.94410946 |
| 58 | TAOK3 | 0.91898149 |
| 59 | JAK2 | 0.91732975 |
| 60 | MKNK2 | 0.91653787 |
| 61 | MARK1 | 0.91237001 |
| 62 | TRIB3 | 0.90596769 |
| 63 | PASK | 0.87749470 |
| 64 | ARAF | 0.87107557 |
| 65 | CAMKK2 | 0.86932390 |
| 66 | SGK3 | 0.85910842 |
| 67 | MAP3K1 | 0.84738214 |
| 68 | CSNK1G1 | 0.84729022 |
| 69 | FGR | 0.84450213 |
| 70 | LYN | 0.83447279 |
| 71 | ALK | 0.82978086 |
| 72 | MAPK11 | 0.81798329 |
| 73 | RIPK1 | 0.81403509 |
| 74 | CSNK1G2 | 0.80519772 |
| 75 | ICK | 0.79472515 |
| 76 | GRK6 | 0.78850195 |
| 77 | SCYL2 | 0.78808894 |
| 78 | MARK2 | 0.78374173 |
| 79 | TIE1 | 0.78032592 |
| 80 | MST4 | 0.77649982 |
| 81 | CDK5 | 0.77060444 |
| 82 | IKBKB | 0.75592708 |
| 83 | MAP3K11 | 0.75393538 |
| 84 | PRKD3 | 0.75243382 |
| 85 | IRAK2 | 0.75213512 |
| 86 | MAPK13 | 0.75153214 |
| 87 | MAPKAPK5 | 0.74215648 |
| 88 | TNK2 | 0.72818178 |
| 89 | NTRK1 | 0.72448465 |
| 90 | GRK5 | 0.71207212 |
| 91 | CAMK2A | 0.68508727 |
| 92 | CAMK2D | 0.67392764 |
| 93 | PNCK | 0.66336539 |
| 94 | PRKCH | 0.65677757 |
| 95 | MAP2K7 | 0.65356151 |
| 96 | PRKCQ | 0.64123657 |
| 97 | TAOK2 | 0.64118291 |
| 98 | STK11 | 0.64003488 |
| 99 | NTRK2 | 0.62897279 |
| 100 | CSF1R | 0.62778962 |
| 101 | YES1 | 0.62675728 |
| 102 | KIT | 0.61749929 |
| 103 | IRAK1 | 0.58847754 |
| 104 | HIPK2 | 0.58786964 |
| 105 | MAP2K3 | 0.58751392 |
| 106 | DYRK2 | 0.58673069 |
| 107 | DAPK1 | 0.58127247 |
| 108 | MAP3K14 | 0.58125983 |
| 109 | PINK1 | 0.57267435 |
| 110 | MET | 0.56816786 |
| 111 | PIM1 | 0.55007120 |
| 112 | LIMK1 | 0.52858115 |
| 113 | RET | 0.52276360 |
| 114 | CDK14 | 0.52102159 |
| 115 | BMPR2 | 0.51907950 |
| 116 | TESK2 | 0.50711625 |
| 117 | CAMK2G | 0.50194275 |
| 118 | CAMK4 | 0.49382481 |
| 119 | CDC42BPA | 0.49337527 |
| 120 | MAP3K7 | 0.48975493 |
| 121 | PAK3 | 0.48701902 |
| 122 | MUSK | 0.48450568 |
| 123 | PRKCE | 0.47671985 |
| 124 | CDK4 | 0.47637765 |
| 125 | CAMK1 | 0.47425594 |
| 126 | BRD4 | 0.47200395 |
| 127 | CDK15 | 0.47055194 |
| 128 | MAPK10 | 0.46710233 |
| 129 | CDK18 | 0.46422197 |
| 130 | MAPK4 | 0.46283439 |
| 131 | PBK | 0.46111598 |
| 132 | DYRK1A | 0.45863196 |
| 133 | KDR | 0.45712013 |
| 134 | TLK1 | 0.42559251 |
| 135 | AKT3 | 0.42526680 |
| 136 | MKNK1 | 0.41615720 |
| 137 | PHKG2 | 0.41585302 |
| 138 | PHKG1 | 0.41585302 |
| 139 | CDK11A | 0.40947798 |
| 140 | FYN | 0.40619399 |
| 141 | TRPM7 | 0.40229234 |
| 142 | CSNK1A1 | 0.39916055 |
| 143 | SGK1 | 0.39268057 |
| 144 | PRKG1 | 0.39025406 |
| 145 | RAF1 | 0.37436512 |
| 146 | PDPK1 | 0.37364474 |
| 147 | CHUK | 0.37333040 |
| 148 | MARK3 | 0.35921856 |
| 149 | TXK | 0.35762094 |
| 150 | MAPK7 | 0.35616399 |
| 151 | ADRBK2 | 0.35611653 |
| 152 | CSK | 0.35020357 |
| 153 | GRK7 | 0.32982520 |
| 154 | INSR | 0.32389972 |
| 155 | CSNK1D | 0.32360527 |
| 156 | ITK | 0.29619812 |
| 157 | ROCK1 | 0.28901827 |
| 158 | GSK3A | 0.28302726 |
| 159 | BMPR1B | 0.27410390 |
| 160 | SGK2 | 0.27391205 |
| 161 | MINK1 | 0.26647489 |
| 162 | PRKCG | 0.26125111 |
| 163 | IRAK4 | 0.25893554 |
| 164 | PLK2 | 0.25749432 |
| 165 | PRKACA | 0.24811853 |
| 166 | STK16 | 0.24266581 |
| 167 | PDK1 | 0.22883193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.38755238 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.20627583 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.77977947 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.64074643 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49808662 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.46770100 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41875322 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.35683452 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.33650560 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25473748 |
| 11 | Axon guidance_Homo sapiens_hsa04360 | 2.24933601 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.21877758 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19593752 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.10571106 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06061967 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99265449 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.94926239 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84989589 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80842237 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.76583821 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76310925 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75236623 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75165119 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.70255727 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67455267 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.62653919 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54121091 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51998139 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51160804 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.49169080 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.48361192 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46079209 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.45323523 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42315520 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41768483 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.41524000 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.41244830 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37452878 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34685928 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33892761 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.30443050 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.28986228 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.27696844 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27268488 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26774712 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26411672 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23560914 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22842240 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21901111 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.21412012 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21316349 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20939876 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19511827 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18581779 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.14945844 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13847457 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.13441171 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.12950640 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11312665 |
| 60 | Glioma_Homo sapiens_hsa05214 | 1.09891043 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07751379 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.07683491 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05650033 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.05444067 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04037581 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02921662 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02558221 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 1.02402513 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01343256 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98515303 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95960530 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95665132 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93945460 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91948398 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91807677 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91317701 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91200120 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91109987 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88669136 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88616196 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88310630 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86966565 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86224985 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85597221 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85229773 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84421637 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.84167979 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83278832 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83208463 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82871518 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82329782 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82189965 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81837877 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81604500 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81394582 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.81089240 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80504765 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.79576773 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77740597 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77281112 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76794397 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76267225 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.75991634 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.75975168 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74283857 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73324240 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.72927449 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72227166 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71359514 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71154703 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69810851 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69337868 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68736542 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.67179484 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67056495 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65858478 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64822130 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63750216 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63510715 |
| 120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63128418 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62916127 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62740148 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62295166 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60634084 |
| 125 | Insulin secretion_Homo sapiens_hsa04911 | 0.60556311 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59283035 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57775232 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56893863 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56810060 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54196756 |
| 131 | Protein export_Homo sapiens_hsa03060 | 0.52387744 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49464371 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49393452 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48879731 |
| 135 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47416161 |
| 136 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46938479 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46643672 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45200597 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43873781 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41334293 |
| 141 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39546648 |
| 142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38685025 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37050084 |
| 144 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36261268 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35976351 |
| 146 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35830137 |
| 147 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30308054 |
| 148 | Allograft rejection_Homo sapiens_hsa05330 | 0.29281989 |
| 149 | Phagosome_Homo sapiens_hsa04145 | 0.29240227 |
| 150 | Alcoholism_Homo sapiens_hsa05034 | 0.28887471 |

